Cervical Cancer Trends Differ by Age - Scorecard - MDSpire

Cervical Cancer Trends Differ by Age

Recent declines among women younger than 35 years contrasted with rising long-term incidence among women aged 35 to 49 years in Puerto Rico

  • By

  • Andrea Surnit

  • May 6, 2026

  • 4 min

Share

Clinical Scorecard: Cervical Cancer Trends Differ by Age

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationWomen in Puerto Rico, particularly those aged 35 to 49 years, with a median diagnosis age of 49.
Care Setting

Key Highlights

  • Impact of Hurricane Maria and COVID-19 on healthcare access and follow-up care needs more specific examples.

Guideline-Based Recommendations

Diagnosis

    Management

    • Assess adherence to screening and timely follow-up care, especially in women aged 35 to 49, with specific strategies.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Lack of individual-level data on HPV vaccination and screening results limits treatment insights.

        Clinical Best Practices

        • Encourage HPV vaccination among adolescents.
        • Maintain stable cervical cancer screening programs.
        • Implement public health interventions targeting women aged 35 to 49.
        • Monitor the impact of external factors on screening and vaccination.

        Related Resources & Content

        Original Source(s)

        Cervical Cancer Trends Differ by Age

        • by Andrea Surnit

        • May 6, 2026

        Related Content

        Medical Oddities: The Economics of Shut-Eye

        Sleep became a commodity, tea became a therapy, and cats got a reprieve this week.

        Women Overdue for Cancer Screenings

        More than 80% of women who were partially up to date reported a wellness visit in the prior year, suggesting missed opportunities for screening engagement in primary care.

        Combination Therapy Shows Potential in Psoriasis, Obesity

        Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.